GE Healthcare Announces FDA Approval Of SenoClaire, New Breast Imaging Eith 3D Tomosynthesis Solution
September 03, 2014 at 07:00 AM EDT
GE Healthcare (NYSE: GE) today announced the FDA approval of SenoClaire*, GE's new breast tomosynthesis solution designed with a ...